Biosimilar medicines – their use in the treatment of inflammatory bowel diseases. Position statement of the Working Group of the Polish National Consultant in Gastroenterology

Biological medical products are drugs whose active components are produced only by living, genetically modified organisms or live cell cultures. Patents and exclusivity for most biopharmaceuticals has either expired or will expire soon, which enables biotechnological companies to introduce similar b...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Mularczyk, Aldona, Gonciarz, Maciej, Bartnik, Witold, Durlik, Marek, Eder, Piotr, Gąsiorowska, Anita, Linke, Krzysztof, Łodyga, Michał, Łykowska-Szuber, Liliana, Małecka-Panas, Ewa, Pawlik, Magdalena, Radwan, Piotr, Rydzewska, Grażyna
Format: Artigo
Jezik:Inglês
Izdano: Termedia Publishing House 2014
Teme:
Research Paper
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4027845/
https://ncbi.nlm.nih.gov/pubmed/24868291
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5114/pg.2014.40842
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items